14-day Premium Trial Subscription Try For FreeTry Free
PerkinElmer's (PKI) urWGS will improve outcomes for critically ill patients in NICUs and PICUs.

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022

02:13pm, Wednesday, 18'th May 2022 Benzinga
Upgrades According to William Blair, the prior rating for On Holding AG (NYSE:ONON) was changed from Sell to Hold. At the moment, the stock has a 52-week-high of $55.87 and a 52-week-low of $16.38. O

Diagnosing PerkinElmer

10:45am, Monday, 16'th May 2022
PerkinElmer has experienced significant growth over the past few years, admittedly with some of it being temporary because of the pandemic. This year should be weaker than last year was, but the overa

PerkinElmer (PKI) Q1 Earnings and Revenues Surpass Estimates

02:54pm, Wednesday, 04'th May 2022 Zacks Investment Research
PerkinElmer's (PKI) first-quarter results benefit from a solid performance at Discover & Analytics Solutions business.
PerkinElmer, Inc. (NYSE:PKI ) Q1 2022 Earnings Conference Call May 3, 2022 5:00 PM ET Company Participants Stephen Willoughby - Vice President of Investor Relations Prahlad Singh - President and Chief

PerkinElmer (PKI) Beats Q1 Earnings and Revenue Estimates

09:25pm, Tuesday, 03'rd May 2022 Zacks Investment Research
PerkinElmer (PKI) delivered earnings and revenue surprises of 15.87% and 6.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PerkinElmer (PKI) delivered earnings and revenue surprises of 15.87% and 6.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PerkinElmer (PKI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PerkinElmer (PKI) to Post Q1 Earnings: What's in the Cards?

12:40pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
PerkinElmer's (PKI) first-quarter results are likely to reflect strong performance at the Diagnostics segment.
PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will release its first quarter 2022 fina

PerkinElmer (PKI) Boosts In Vivo Imaging Profile With New System

01:16pm, Friday, 08'th Apr 2022 Zacks Investment Research
PerkinElmer's (PKI) launch of the Vega imaging system is likely to help the company expand its in vivo imaging portfolio.
PerkinElmer's (PKI) launch of the Vega imaging system is likely to help the company expand its in vivo imaging portfolio.

PerkinElmer's (PKI) New Assay Kits to Detect CHO HCP Impurities

03:12pm, Thursday, 07'th Apr 2022 Zacks Investment Research
PerkinElmer (PKI) launches ready-to-use HTRF and AlphaLISA no-wash assay kits to quickly identify and quantify CHO HCP impurities.
PerkinElmer (PKI) launches ready-to-use HTRF and AlphaLISA no-wash assay kits to quickly identify and quantify CHO HCP impurities.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE